Anti-nerve growth factor (NGF) antibody compositions

Details for Australian Patent Application No. 2011227335 (hide)

Owner Abbott Research B.V.

Inventors Fraunhofer, Wolfgang; Chari, Ravi; Kumar, Vineet; Saedler, Rainer; Siedler, Michael; Stine, William B.; Weber, Carsten

Agent Spruson & Ferguson

Pub. Number AU-A-2011227335

PCT Pub. Number WO2011/116090

Priority 61/314,984 17.03.10 US

Filing date 16 March 2011

Wipo publication date 22 September 2011

International Classifications

C07K 16/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/22 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

20 September 2012 PCT application entered the National Phase

  PCT publication WO2011/116090 Priority application(s): WO2011/116090

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011227345-Wave-energy converter

2011227329-Adjusting pump flow at tool